0.53

0.93% -0.005

Reviva Pharmaceuticals Holdings Inc (RVPH)

Overview News Price History Option Chain Financials Discussions Forecast

Reviva Pharmaceuticals Holdings Inc stock is traded at $0.53, with a volume of 23,593. It is down -0.93% in the last 24 hours and down -24.07% over the past month. REVIVA PHARMA HLDGS INC

Previous Close:

$0.535

Open:

$0.5299

24h Volume:

23,593

Relative Volume:

5.33

Market Cap:

$N/A

Revenue:

Net Income/Loss:

$-16.63M

P/E Ratio:

-0.1162

EPS:

-4.5609

Net Cash Flow:

$-20.20M

1W Performance:

+5.51%

1M Performance:

-24.07%

6M Performance:

-96.15%

1Y Performance:

-98.07%

1-Day Range:

$0.51

$0.555

1-Week Range:

$0.47

$0.555

52-Week Range:

$0.46

$0.7499

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile

Name

Reviva Pharmaceuticals Holdings Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

RVPH's Discussions on Twitter

Compare RVPH vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RVPH Reviva Pharmaceuticals Holdings Inc	0.53	0	0	-16.63M	-20.20M	-4.5609
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-05-26	Downgrade	D. Boral Capital	Buy → Hold
Sep-29-25	Initiated	Chardan Capital Markets	Buy
Sep-20-23	Initiated	ROTH MKM	Buy
Jun-08-23	Initiated	The Benchmark Company	Speculative Buy
Jan-24-22	Initiated	H.C. Wainwright	Buy

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News

Aug 20, 2026

Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Stock Price, News & Analysis - Kalkine

Aug 20, 2026

Reviva (RVPH) Results Review: EPS Lands Above Forecast in Latest Trading; Share Response: Shares Move 8.70% HigherProfit Recovery Report - vinanet.vn

Aug 20, 2026

Aug 17, 2026

RVPH: Patent Filed for New Formulation - Yahoo Finance

Aug 17, 2026

Aug 14, 2026

Reviva Pharmaceuticals Holdings Stock Price Forecast. Should You Buy RVPH? - StockInvest.us

Aug 14, 2026

Reviva Pharmaceuticals Holdings, Inc. Stock (RVPH)Quote OTC Markets - marketscreener.com

Aug 14, 2026

OTC Market Listing Exposes Reviva Pharmaceuticals to Volatility, Illiquidity and Pricing Risks - TipRanks

Aug 14, 2026

Aug 13, 2026

Barclays PLC (RVPH) discloses 20-share beneficial stake in Reviva common stock - Stock Titan

Aug 13, 2026

Aug 12, 2026

Reviva Q2 loss narrows to $2.4m; EPS beats estimate - scanx.trade

Aug 12, 2026

Form 8K Reviva Pharmaceuticals Holdings, Inc. For: 12 August By Investing.com - Investing.com Nigeria

Aug 12, 2026

Reviva Q2 loss narrows as brilaroxazine milestones approach - Quiver Quantitative

Aug 12, 2026

Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times

Aug 12, 2026

Reviva Seeks Accelerated Patent Review for Drug Through 2046 - Stock Titan

Aug 12, 2026

Aug 11, 2026

RVPH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 6.36% Stock AdvanceSpecial Dividend Alert - vinanet.vn

Aug 11, 2026

Aug 07, 2026

RVPH Q1 2026 Earnings: Narrower Loss Beats Estimates by 27.49%Product Revenue Analysis - vinanet.vn

Aug 07, 2026

Aug 03, 2026

Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake - Stock Titan

Aug 03, 2026

Jul 31, 2026

Reviva Pharmaceuticals (RVPH) Soars 17.47% to $0.47, Testing Key Resistance ZoneOvernight Profile - dars.gov.et

Jul 31, 2026

Jul 29, 2026

Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Surprises, Stock Dips on No Revenue Milestones - dars.gov.et

Jul 29, 2026

Jul 28, 2026